Ajax-Loading

WuXi Biologics - Net Receivables

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Net-Receivables" stands at 7.03 Billion Chinese Yuans as of 06/30/2025, the highest value at least since 03/31/2015, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.74 percent compared to the value the year prior.
The 1 year change in percent is 13.74.
The 3 year change in percent is 26.35.
The 5 year change in percent is 216.46.

The Serie's long term average value is 3.18 Billion Chinese Yuans. It's latest available value, on 06/30/2025, is 121.23 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 06/30/2025, is +5,281.92%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.

Net Receivables for Related Companies:

LogoNameMarket Cap (USD)
LogoThermo Fisher Scientific Inc - Net Receivables215,194,320,896.00
LogoAgilent Technologies Inc - Net Receivables41,246,478,336.00
LogoWuXi AppTec Co Ltd - Net Receivables38,655,022,911.83
LogoIQVIA Holdings Inc - Net Receivables38,462,255,104.00
LogoMettler-Toledo International Inc - Net Receivables29,144,758,272.00